Newtyn Management
Latest statistics and disclosures from Newtyn Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CNNE, IAC, PAR, GIII, MACK, and represent 45.91% of Newtyn Management's stock portfolio.
- Added to shares of these 10 stocks: MDRX (+$15M), IAC (+$15M), OFIX (+$14M), MITK (+$13M), AIV (+$11M), CNNE (+$11M), PAR (+$9.8M), VTOL, MBI, MURA.
- Started 9 new stock positions in MITK, MURA, NUKK, MDRX, VNDA, Homology Medicines, NBBK, OFIX, ADPT.
- Reduced shares in these 10 stocks: AMBP (-$18M), TSVT (-$12M), PFSweb (-$5.3M), TLYS, GTX, , ONL, GLPG, GIII, Graphite Bio.
- Sold out of its positions in DXLG, Graphite Bio, MRSN, ONL, PFSweb, TSVT, Brilliant Acquisition Rts.
- Newtyn Management was a net buyer of stock by $61M.
- Newtyn Management has $509M in assets under management (AUM), dropping by 25.72%.
- Central Index Key (CIK): 0001569241
Tip: Access up to 7 years of quarterly data
Positions held by Newtyn Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Newtyn Management
Newtyn Management holds 48 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cannae Holdings (CNNE) | 13.1 | $67M | +19% | 3.4M | 19.51 |
|
| Iac Com New (IAC) | 12.4 | $63M | +30% | 1.2M | 52.38 |
|
| PAR Technology Corporation (PAR) | 10.3 | $53M | +22% | 1.2M | 43.54 |
|
| G-III Apparel (GIII) | 5.1 | $26M | -7% | 760k | 33.98 |
|
| Merrimack Pharmaceuticals In Com New (MACK) | 4.9 | $25M | 1.9M | 13.41 |
|
|
| Bristow Group (VTOL) | 4.8 | $24M | +24% | 863k | 28.27 |
|
| Theravance Biopharma (TBPH) | 4.2 | $21M | +3% | 1.9M | 11.24 |
|
| Spectrum Brands Holding (SPB) | 3.9 | $20M | 250k | 79.77 |
|
|
| City Office Reit (CIO) | 3.8 | $20M | 3.2M | 6.11 |
|
|
| Allscripts Healthcare Solutions (MDRX) | 3.0 | $15M | NEW | 1.5M | 10.49 |
|
| Orthofix Medical (OFIX) | 2.8 | $14M | NEW | 1.1M | 13.48 |
|
| Bv Finl Com New (BVFL) | 2.8 | $14M | +13% | 1.0M | 14.18 |
|
| Apartment Invt & Mgmt Cl A (AIV) | 2.6 | $13M | +628% | 1.7M | 7.83 |
|
| Mitek Sys Com New (MITK) | 2.5 | $13M | NEW | 993k | 13.04 |
|
| Mbia (MBI) | 2.3 | $12M | +31% | 1.9M | 6.12 |
|
| Garrett Motion (GTX) | 2.0 | $10M | -22% | 1.0M | 9.67 |
|
| Ardagh Metal Packaging S A SHS (AMBP) | 1.9 | $9.5M | -65% | 2.5M | 3.84 |
|
| Cyteir Therapeutics | 1.8 | $9.2M | +20% | 3.0M | 3.04 |
|
| Galapagos Nv Spon Adr (GLPG) | 1.7 | $8.9M | -20% | 218k | 40.65 |
|
| Ni Hldgs (NODK) | 1.4 | $6.9M | +12% | 531k | 12.99 |
|
| Star Hldgs Shs Ben Int (STHO) | 1.3 | $6.7M | +36% | 446k | 14.98 |
|
| Algoma Stl Group (ASTL) | 1.2 | $5.9M | 591k | 10.03 |
|
|
| Phathom Pharmaceuticals (PHAT) | 1.2 | $5.9M | +29% | 647k | 9.13 |
|
| Forum Energy Technologies In Note 9.000% 8/0 (Principal) | 1.1 | $5.4M | 5.5M | 0.99 |
|
|
| Kodiak Sciences (KOD) | 1.1 | $5.4M | +10% | 1.8M | 3.04 |
|
| PG&E Corporation (PCG) | 1.0 | $4.8M | 269k | 18.03 |
|
|
| Forum Energy Technologies In (FET) | 0.8 | $4.3M | +6% | 194k | 22.17 |
|
| Avrobio Ord (AVRO) | 0.7 | $3.7M | +36% | 2.7M | 1.36 |
|
| 89bio (ETNB) | 0.6 | $3.0M | +35% | 273k | 11.17 |
|
| Mural Oncology Pub Ord Shs (MURA) | 0.5 | $2.6M | NEW | 445k | 5.92 |
|
| Wave Life Sciences SHS (WVE) | 0.5 | $2.6M | 510k | 5.05 |
|
|
| Olema Pharmaceuticals (OLMA) | 0.4 | $2.1M | 150k | 14.03 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.7M | +52% | 1.6M | 1.12 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.3 | $1.6M | NEW | 322k | 4.90 |
|
| Atea Pharmaceuticals (AVIR) | 0.3 | $1.6M | +27% | 509k | 3.05 |
|
| Vanda Pharmaceuticals (VNDA) | 0.2 | $1.2M | NEW | 290k | 4.22 |
|
| Sensei Biotherapeutics (SNSE) | 0.2 | $1.1M | -12% | 1.6M | 0.69 |
|
| Homology Medicines | 0.2 | $851k | NEW | 1.4M | 0.61 |
|
| Aligos Therapeutics (ALGS) | 0.2 | $833k | +36% | 1.3M | 0.66 |
|
| Black Diamond Therapeutics (BDTX) | 0.2 | $787k | +36% | 280k | 2.81 |
|
| Nb Bancorp (NBBK) | 0.1 | $631k | NEW | 47k | 13.45 |
|
| Adverum Biotechnologies | 0.1 | $620k | -19% | 823k | 0.75 |
|
| Tillys Cl A (TLYS) | 0.1 | $473k | -90% | 63k | 7.54 |
|
| Arca Biopharma (ABIO) | 0.1 | $458k | -10% | 269k | 1.70 |
|
| Nukkleus Ord (NUKK) | 0.0 | $77k | NEW | 27k | 2.85 |
|
| Arisz Acquisition Corp Right 99/99/9999 | 0.0 | $53k | 250k | 0.21 |
|
|
| Viveon Health Acquisition Right 12/31/2025 (VHAQR) | 0.0 | $11k | 250k | 0.04 |
|
|
| Leafly Holdings *w Exp 02/04/202 (LFLYW) | 0.0 | $10k | 635k | 0.02 |
|
Past Filings by Newtyn Management
SEC 13F filings are viewable for Newtyn Management going back to 2012
- Newtyn Management 2023 Q4 filed Feb. 14, 2024
- Newtyn Management 2023 Q3 filed Nov. 14, 2023
- Newtyn Management 2023 Q2 filed Aug. 14, 2023
- Newtyn Management 2023 Q1 filed May 15, 2023
- Newtyn Management 2022 Q4 filed Feb. 14, 2023
- Newtyn Management 2022 Q3 filed Nov. 14, 2022
- Newtyn Management 2022 Q2 filed Aug. 15, 2022
- Newtyn Management 2022 Q1 filed May 16, 2022
- Newtyn Management 2021 Q4 filed Feb. 14, 2022
- Newtyn Management 2021 Q3 filed Nov. 15, 2021
- Newtyn Management 2021 Q2 filed Aug. 16, 2021
- Newtyn Management 2021 Q1 filed May 17, 2021
- Newtyn Management 2020 Q4 filed Feb. 16, 2021
- Newtyn Management 2020 Q3 filed Nov. 16, 2020
- Newtyn Management 2020 Q2 filed Aug. 14, 2020
- Newtyn Management 2020 Q1 filed May 15, 2020